Metropolitan Life Insurance Company (MetLife)’s Centene CNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,556
| Closed | -$1.69M | – | 460 |
|
|
2024
Q1 | $1.69M | Sell |
21,556
-188
| -0.9% | -$14.5K | 0.07% | 231 |
|
|
2023
Q4 | $1.61M | Sell |
21,744
-659
| -3% | -$47.5K | 0.08% | 219 |
|
|
2023
Q3 | $1.54M | Sell |
22,403
-1,511
| -6% | -$101K | 0.08% | 214 |
|
|
2023
Q2 | $1.61M | Sell |
23,914
-719
| -3% | -$47.9K | 0.08% | 228 |
|
|
2023
Q1 | $1.56M | Sell |
24,633
-8,118
| -25% | -$576K | 0.08% | 229 |
|
|
2022
Q4 | $2.69M | Sell |
32,751
-1,277
| -4% | -$104K | 0.12% | 168 |
|
|
2022
Q3 | $2.65M | Sell |
34,028
-1,200
| -3% | -$107K | 0.13% | 156 |
|
|
2022
Q2 | $2.98M | Sell |
35,228
-781
| -2% | -$64.9K | 0.13% | 153 |
|
|
2022
Q1 | $3.03M | Sell |
36,009
-30,591
| -46% | -$2.51M | 0.11% | 178 |
|
|
2021
Q4 | $5.49M | Sell |
66,600
-1,889
| -3% | -$138K | 0.07% | 209 |
|
|
2021
Q3 | $4.27M | Sell |
68,489
-2,294
| -3% | -$153K | 0.06% | 248 |
|
|
2021
Q2 | $5.16M | Sell |
70,783
-9,810
| -12% | -$672K | 0.07% | 210 |
|
|
2021
Q1 | $5.15M | Sell |
80,593
-4,039
| -5% | -$250K | 0.08% | 201 |
|
|
2020
Q4 | $5.08M | Sell |
84,632
-4,106
| -5% | -$261K | 0.08% | 201 |
|
|
2020
Q3 | $5.18M | Sell |
88,738
-3,744
| -4% | -$233K | 0.09% | 180 |
|
|
2020
Q2 | $5.88M | Sell |
92,482
-18,427
| -17% | -$1.2M | 0.1% | 157 |
|
|
2020
Q1 | $6.59M | Buy |
110,909
+31,736
| +40% | +$1.93M | 0.14% | 141 |
|
|
2019
Q4 | $4.98M | Sell |
79,173
-317
| -0.4% | -$17.2K | 0.08% | 212 |
|
|
2019
Q3 | $3.44M | Sell |
79,490
-512
| -0.6% | -$24.9K | 0.06% | 289 |
|
|
2019
Q2 | $4.2M | Buy |
80,002
+3,344
| +4% | +$181K | 0.07% | 240 |
|
|
2019
Q1 | $4.07M | Sell |
76,658
-1,698
| -2% | -$103K | 0.07% | 223 |
|
|
2018
Q4 | $4.52M | Buy |
78,356
+814
| +1% | +$54.5K | 0.09% | 188 |
|
|
2018
Q3 | $5.61M | Sell |
77,542
-1,878
| -2% | -$130K | 0.1% | 180 |
|
|
2018
Q2 | $4.89M | Buy |
79,420
+24,576
| +45% | +$1.42M | 0.08% | 213 |
|
|
2018
Q1 | $2.93M | Buy |
54,844
+568
| +1% | +$29.6K | 0.04% | 334 |
|
|
2017
Q4 | $2.74M | Sell |
54,276
-111,318
| -67% | -$5.39M | 0.04% | 361 |
|
|
2017
Q3 | $8.01M | Sell |
165,594
-3,258
| -2% | -$140K | 0.05% | 332 |
|
|
2017
Q2 | $6.74M | Sell |
168,852
-11,986
| -7% | -$452K | 0.05% | 399 |
|
|
2017
Q1 | $6.44M | Sell |
180,838
-1,572
| -0.9% | -$52.6K | 0.04% | 430 |
|
|
2016
Q4 | $5.15M | Sell |
182,410
-2,828
| -2% | -$83.4K | 0.04% | 551 |
|
|
2016
Q3 | $6.2M | Sell |
185,238
-1,794
| -1% | -$62.3K | 0.05% | 416 |
|
|
2016
Q2 | $6.67M | Sell |
187,032
-1,610
| -0.9% | -$50.6K | 0.05% | 375 |
|
|
2016
Q1 | $5.81M | Sell |
188,642
-32,192
| -15% | -$961K | 0.04% | 434 |
|
|
2015
Q4 | $7.27M | Buy |
220,834
+1,528
| +0.7% | +$45.3K | 0.06% | 327 |
|
|
2015
Q3 | $5.95M | Sell |
219,306
-1,528
| -0.7% | -$51.1K | 0.04% | 422 |
|
|
2015
Q2 | $8.88M | Buy |
220,834
+2,270
| +1% | +$81.5K | 0.06% | 299 |
|
|
2015
Q1 | $7.72M | Buy |
218,564
+9,688
| +5% | +$291K | 0.06% | 340 |
|
|
2014
Q4 | $5.42M | Buy |
208,876
+2,444
| +1% | +$57K | 0.04% | 502 |
|
|
2014
Q3 | $4.27M | Buy |
206,432
+190,484
| +1,194% | +$3.67M | 0.03% | 584 |
|
|
2014
Q2 | $301K | Sell |
15,948
-158,296
| -91% | -$2.72M | ﹤0.01% | 2201 |
|
|
2014
Q1 | $2.71M | Sell |
174,244
-628
| -0.4% | -$9.72K | 0.02% | 827 |
|
|
2013
Q4 | $2.58M | Buy |
174,872
+3,876
| +2% | +$58K | 0.02% | 842 |
|
|
2013
Q3 | $2.73M | Sell |
170,996
-564
| -0.3% | -$8.12K | 0.02% | 771 |
|
|
2013
Q2 | $2.25M | Buy |
+171,560
| New | +$2.08M | 0.02% | 822 |
|
Other funds holding CNC
PCM
Metropolitan Life Insurance Company (MetLife)'s CNC Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Centene (CNC) in Q2 2024, closing a stake of 21,556 shares — an estimated $1.69M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in CNC in Q2 2013 and held it in 44 quarters. The position peaked at $8.88M in Q2 2015. 896 funds tracked by Wall St. Rank hold CNC as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Centene position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 21,556 Centene shares in Q2 2024, an estimated $1.69M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Centene in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Centene position peaked at $8.88M in Q2 2015.
- 896 funds tracked by Wall St. Rank held Centene as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.